| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582445 Anti-interferon-α antibodies |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | US7582311 Comprising hyaluronic acid or sodium hyaluronate dissolved in physiological buffer at concentration of 0.01-3 percent weight per volume and particles comprising first component biologically active agent and second component biocompatible polymeric matrix; use of 23-gauge or smaller bore needle |
| 09/01/2009 | CA2490115C Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 09/01/2009 | CA2393344C Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 08/27/2009 | WO2009104706A1 Microparticles and pharmaceutical compositions thereof |
| 08/27/2009 | WO2009103637A1 Method for generating islet beta cells from dedifferentiated exocrine pancreatic cells |
| 08/27/2009 | WO2009083272A3 19-NOR-STEROID DERIVATIVES WITH A 15α,16α-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES |
| 08/27/2009 | WO2009073544A3 Methods for treating a disorder by regulating gprc6a |
| 08/27/2009 | WO2007003934A3 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 08/27/2009 | US20090217392 Anti- integrin antibodies, compositions, methods and uses |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 08/27/2009 | US20090215748 FXR agonists for treating vitamin D associated diseases |
| 08/27/2009 | CA2715665A1 Microparticle and pharmaceutical composition thereof |
| 08/26/2009 | EP2093228A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 08/26/2009 | EP2091922A2 2-[1-phenyl-5-hydroxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 08/26/2009 | EP1752155A4 Compositions for correcting age related changes of a human endocrine system and methods for producing a pharmaceutical form bases on said compositions |
| 08/26/2009 | EP1462442B1 Crystals of bicalutamide and process for their production |
| 08/26/2009 | CN101516890A Diaryl ketimine derivative |
| 08/26/2009 | CN101516849A 5-phenyl-nicotinamide derivatives |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579435 Somatostatin-dopamine chimeric analogs |
| 08/25/2009 | CA2414967C Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/20/2009 | WO2009101165A1 Composition for absorption through mucous tissue |
| 08/20/2009 | US20090209655 Isoflavone metabolites |
| 08/20/2009 | US20090209653 Agent for increasing testosterone level |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209559 Pharmaceutical compounds |
| 08/20/2009 | US20090209501 Method of treating and preventing secondary hyperparathyroidism |
| 08/19/2009 | EP2090656A1 Mutant androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 08/19/2009 | EP1343509B1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | CN101511857A 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same |
| 08/19/2009 | CN101511367A Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/19/2009 | CN101511205A Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |
| 08/19/2009 | CN100529074C Therapeutic binding molecules |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/19/2009 | CN100528168C 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 08/18/2009 | US7576200 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 08/18/2009 | US7576095 2-(p-Alkoxy- or p-fluoroalkylsulonyloxyphenyl)-1-phenyl-5-cyclohexyl- or 5-(1-piperdinyl)-4,5-dihydropyrrolo[3,2-c]pyridin-4-ones; treatment of obesity, psychiatric and neurological disorders |
| 08/18/2009 | CA2429133C Novel imidazole derivatives, production method thereof and use thereof |
| 08/18/2009 | CA2226425C Drug delivery compositions for improved stability of steroids |
| 08/13/2009 | WO2009008727A3 Molecules for targeting compounds to various selected organs or tissues |
| 08/13/2009 | WO2008148839A3 Long-acting polymeric prodrugs of exendin |
| 08/13/2009 | WO2008129396A3 Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding |
| 08/13/2009 | US20090203782 Alpha 2 Delta Ligands for Fibromyalgia and Other Disorders |
| 08/13/2009 | US20090203710 Novel piperidine derivative |
| 08/13/2009 | US20090203633 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/13/2009 | US20090202591 Leucine-based motif and clostridial neurotoxins |
| 08/12/2009 | EP2086957A1 Sulphamate benzothiophene derivatives |
| 08/12/2009 | EP2086539A1 Selective glycosidase inhibitors |
| 08/12/2009 | EP1567150B1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 08/12/2009 | EP1515959B1 Pharmaceutical salts of reboxetine |
| 08/12/2009 | EP1409645B1 Probiotic lactobacillus salivarius strains |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP1379257B1 Prodrugs of anticancer agents employing substituted aromatic acids |
| 08/12/2009 | EP1290227B1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 08/12/2009 | EP1077941B1 Compounds with growth hormone releasing properties |
| 08/12/2009 | CN101506221A Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors |
| 08/12/2009 | CN101506158A Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 08/12/2009 | CN101505789A A stable liquid formulation of human growth hormone |
| 08/12/2009 | CN101505739A Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith |
| 08/11/2009 | US7572883 Somatostatin-dopamine chimeric analogs |
| 08/11/2009 | US7572779 Improved oral bioavailability of 17 beta-estradiol by adminstering the lower alkanoate; contraceptives, hormone replacement therapy |
| 08/11/2009 | US7572765 polypeptides or fragments used for treating bone disorders such as osteoporosis |
| 08/11/2009 | US7572605 1,2,3,tris(4-hydroxy-butyroyloxy)propane; enhance the uptake of the drug, deliver effective therapeutic doses in a time-delayed fashion, and target specific organs |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/06/2009 | WO2009097416A1 Imidazolylalkyl- pyridines as dbh inhibitors |
| 08/06/2009 | WO2009095418A1 Use of ulipristal for treating uterine fibroids |
| 08/06/2009 | WO2009069032A3 Novel glucocorticoid receptor agonists |
| 08/06/2009 | WO2009065126A3 Excipients for protein stabilization |
| 08/06/2009 | WO2009062082A3 Selective estrogen receptor modulator compositions and methods for treatment of disease |
| 08/06/2009 | WO2009040086A3 Use of salusin-alpha as a therapeutic agent |
| 08/06/2009 | US20090197965 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 08/06/2009 | US20090197909 Bis-Heterocyclic Imidazolyl Compounds |
| 08/06/2009 | US20090197815 Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist |
| 08/06/2009 | US20090197813 Methods for treating FSH related conditions with GnRH antagonists |
| 08/06/2009 | US20090197802 Analogues of GLP-1 |
| 08/06/2009 | US20090196941 Extracts from Rhodiola, Panax, Pfaffia, Astragalus, Echinacea, Dioscorea, Ganoderma, Grifola frondosa mushroom, Tabebuia, Uncaria, Vitex agnus castus and Hydrococtile; for prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders; side effects reduction |
| 08/05/2009 | EP2085406A1 Long lasting insulin derivatives and methods thereof |
| 08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085388A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085387A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085383A1 Piperidine derivatives or salts thereof |
| 08/05/2009 | EP2085094A2 Application of aminopeptidases inhibitors and pharmaceutical preparations containing same |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | CN101500561A Treatment of endocrine dysfunction using iron chelators |
| 08/05/2009 | CN101496828A Use of total saponin extract of fenugreek |
| 08/05/2009 | CN100522976C Novel azacyclic ethynyl derivatives |
| 08/05/2009 | CN100522960C Thioamide derivatives as progesterone receptor modulators |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522239C Pharmaceutical formulations for sustained drug delivery |
| 08/05/2009 | CN100522151C Compounds for treatment of inflammation, diabetes and related disorders |